Search
Search
Close this search box.

Pioneering medical cannabis university course in Berlin celebrates end of first year

The first class on a pioneering university medical cannabis course have concluded their first year of studies.

The research programme at the Humboldt-Universitat zu Berlin examines the medical and nutritional uses of cannabis, production and the legal and economic frameworks of the business.

It’s the latest sign that medical cannabis is becoming a part of the mainstream education offering and a positive indication that new industry leaders will emerge in the coming years.

Fifteen students dedicated their year to the technical course, which is still one of very few like it in Europe.

The course was supported by German medical cannabis firm Aurora Europe. Its president Dr Axel Gille said: “We were amazed by the results and the commitment of the scholars.

“They have shown in many ways how one can take a more differentiated view of medical cannabis and how many open questions can still be exposed and researched.

The Berlin university has followed the lead of several US colleges

“I am confident that the still prevalent stigma and prejudices surrounding medical cannabis will be overcome by collaborating with young scientists and leading scientific institutions.”

As the medical cannabis industry continues to grow, education institutions are increasingly looking to cash in and attract bright young minds targeting a career in the sector.

The University of Maryland in Baltimore became the first US college to offer a masters degree in medical science cannabis and therapeutics in 2019. Several others have followed suit.

Professor Christian Ulrichs, scientific head of the class, praised the students and said some would go on to continue research in the field.

He said: “I was particularly impressed by the determination of the students who went to great lengths even in the difficult times of the pandemic.

“Personally I am very please about these young, talented students who have started their doctorate here but also at other institutions following this class.

“Some are furthering their research on medical cannabis which is a testament to the success of this programme.

“New research questions have developed out of this themed class which the scientific team will now research with scientific and commercial partners in Germany but also in countries such as Brazil and Mexico.”

[activecampaign form=31]

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?